Microwave Assisted Improved Synthesis of Some Novel Heterofused Pyrazolopyrimidines Derivatives and Their Antimicrobial Activity

 

Sharma Bindiya1, Jain Anamika2, Sharma Dipak3 and Dubey Arti4

1Dept. of Engineering Chemistry, Chameli Devi Group of Institutions, Indore (MP), India

2Dept. of Chemistry, Mata Jigabai Govt. Post Graduate Girls' College, Indore (MP), India

3Dept. of Chemical Sciences, Mahahraja Ranjit Singh College, Indore (MP), India

Corresponding author: bindiya12july@yahoo.com

 

ABSTRACT:

Heterofused pyrazolopyrimidines possesses various biological activities such as CNS depressant, neuroleptic, tuberculostatic, antimicrobial, adenosine receptor antagonistic, antinociceptive, anti-inflammatory, non-narcotic analgesic, anticancer and leishmanicidal activity.

Therefore, in this work, we have synthesized some new Heterofused containing disubstitued Pyrazolopyrimidines employing microwave techniques and have been evaluated for their antimicrobial activity. Substituted 5-amino-1-Phenyl Pyrazole-4-Carboxamide was reacted with appropriate amount of Ethyl formate in the presence of Sodium ethoxide solution to furnish titled compounds. Neat reactants were cyclocondensed under microwaves to afford, in good yield, the desired product in less irradiation times as compared to the classical technique.

All the synthesized compounds were characterized by melting point, Rf value and further confirmed by UV, IR, H1NMR and Mass spectroscopy.

The title compounds were screened for antibacterial activity by cup plate method using Streptomycin as the standard drug against Klebsiella (Gram –ve), Escherichia coli (Gram –ve), Staphylococcus aureus (Gram +ve) and Bacillus subtillis (Gram +ve). All the compounds showed weak to moderate activity against all four microorganisms.

 

KEYWORDS: Heterofused, microwave assisted, pyrazolopyrimidines, antimicrobial activity.

 


 

INTRODUCTION:

Heterocyclic compounds are acquiring more importance in recent years due to the pharmacological activities. Nitrogen, sulphur, oxygen, containing five/six member heterocyclic compounds has occupied enormous significance in the field of drug discovery process. Substituted oxazole, pyrazole and their analogs have been used as precursors for synthesis of various biologically active molecules, oxazole derivatives as brain-derived neurotrophic factor inducers1, analgesic2, trypanocidal activity3, anti-mitotic agents with pro-apoptotic activity4, antifungal activity5, anti-inflammator6, anti-depressant7, anti-cancer8, anti-microbial, anti-diabetic and anti-obesity 9-10.

 

An antibiotic is a drug extracted from fungus or other microorganism that kills or slows the growth of bacteria. Antibiotics are one class of antimicrobials, a larger group which also includes anti-viral, anti-fungal and anti-parasitic drugs.

 

They are relatively harmless to the host and therefore can be used to treat infections11. Antibiotic resistance occurs when bacteria change in some way that reduces or eliminates the effectiveness of drugs, chemicals or other agents designed to cure or prevent infections. Obviously, if a bacterial pathogen is able to develop or acquire resistance to an antibiotic then that substance becomes useless in the treatment of infectious disease caused by that pathogen. So, as pathogens develop resistance, we must find novel drugs to fill the place of the old ones in treatment regimes.12.

 

To achieve the above-mentioned target, scientists have utilized the concept of bioisosterism. The concept and study of bioisosterism is a central theme in drug design and development. It is now known that many heterocycles, when appropriately substituted, display bioisosterism.

 

Pyrazole and pyrimidine derivatives attracted organic chemists very much due to their biological and chemotherapeutic importance. Pyrazolopyrimidines and related fused heterocycles are of interest as potential bioactive molecules because there is not much difference in the basic structures of pyrazolopyrimidines and purines. In many cases, heterocyclic fusion of pyrimidine ring and pyrazole ring resulted in compounds with wide spectrum of biological activities. Some of the activities possessed by heterofused pyrazolopyrimidines include CNS depressant13, neuroleptic13, tuberculostatic13 ,antimicrobial13,14, anticancer14,15, adenosine receptor antagonistic16-18, antinociceptive19, anti-inflammatory19,20, non-narcotic analgesic20 and leishmanicidal21 activity.

 

However, literature survey showed that a few attempts were made to synthesize heterofused pyrazolopyrimidine ring system for the evaluation of antibacterial activity22, 23. In the recent years, the efficiency of microwave chemistry in dramatically reducing reaction times has recently been proven in several different fields of organic chemistry24, microwave-assisted organic synthesis has shown significant improvement in the generation of combinatorial libraries of small molecules25. In general, microwave irradiation was found to be very useful to accelerate the rate of reaction of various thermally conducted reactions and also this technique was found to be very useful to improve an overall yield and reaction selectivity. Moreover, microwave chemistry assures safe and reproducible experimental procedures. Thus, in the present investigation, along with the conventional method, we decided to develop microwave-assisted one-pot facile method for the synthesis of 6-substituted1-phenyl-1 H-pyrazolo[3,4-pyrimidin-4[5H]-one, as a new class of antimicrobial agents.

 

MATERIAL AND METHODS:

All the chemicals were of synthetic grade and commercially procured from S.D. fine. Melting points were determined in open capillary tubes and are uncorrected. IR spectra carried out by spectrophotometer. Peak values are shown in ppm, in the d scale. All reactions were followed and checked by TLC (Chloroform: Ehtyl acetate (7:3)).

 

Synthesis Protocol:

Synthesis of 5-amino-1-phenyl pyrazole-4-carboxamide (APPC) (1a-c)

Synthesis of 5-amino-1-phenyl pyrazole-4-carboxamide was carried out using a literature procedure and their spectral data are given below.

1.      Synthesis of Ethoxymethylenemalanonitrile (EMMN): (1a)

Rf 0.64 (Chloroform : Ethyl acetate (7 : 3)), IR (cm-1): IR (KBr) : 3025.2 cm–1 (=C–H); 2941.2 cm–1            (–CH2–); 2228.3 cm–1 (–CN); 1615.8 cm–1 (C=C); 1012.6 cm–1 (=C–O); C6H6N2O (M.Wt. 122).

 

2.      Synthesis of 5-amino-4-cyano-1-phenyl pyrazole (ACPP): (1b)

Rf 0.57 (Chloroform : Ethyl acetate (7 : 3)), IR (cm-1): IR (KBr) : 3324.7 cm–1,3221.3 cm–1 (–NH2); 3053.2 cm–1 (=C–H, aromatic); 2218.5 cm–1 (–CN); 1638.5 cm–1 (–C=N); 763.6 cm–1 (–CH oop). Note: oop – out of plane; C10H8N4 (M.Wt. 184)

 

3.      Synthesis of 5 -amino-1-phenyl pyrazole-4-carboxamide (APPC): (1c)

Rf 0.20 Chloroform : Ethyl acetate (7 : 3)),  IR (cm-1): IR (KBr) : 3322.1 cm–1, 3180.1 cm–1 (–NH2); 1647.6 cm–1 (–C=O); 1557.8 cm–1 (–C=N); 1336.7 cm–1 (=C–N); 734.8 cm–1 (–CH oop);  C10H10N4O (M.Wt. 202)

 

Method A:

Compound (1) (APPC)  (0.01 M; 2.02 g) and Ethyl formate (2) (0.02 M; 1.48 g/1.6 ml) were added in the presence of sodium ethoxide (prepared from 1.1 g of sodium in 60 ml of ethanol).  The reaction mixture was heated to reflux for 14 hours in an oil bath. The resulting solution was concentrated under reduced pressure to dryness and the residue was dissolved in 500 ml of water. The insoluble impurities were removed by filtration; the filtrate was neutralized with dilute hydrochloric acid. The solid thus obtained was filtered, dried and recrystallized from methanol to obtain compound, 6-substituted1-phenyl-1 H-pyrazolo[3,4-pyrimidin-4[5H]-one (3).

 

Method B:

Compound (1) (APPC) (0.01 M; 2.02 g) and Ethyl formate (2) (0.02 M; 1.48 g/1.6 ml) were added in the presence of sodium ethoxide (prepared from 1.1 g of sodium in 60 ml of ethanol).  The reaction mixture was taken in a test tube and irradiated for 3 minutes at 960 watt using domestic microwave oven (Whirlpool 20G(M)). The reaction mixture was poured onto crushed ice and insoluble impurities were removed by filtration. The filtrate was neutralized with dilute hydrochloric acid. The solid thus obtained was filtered, dried and recrystallized from methanol to obtain compound 6-substituted1-phenyl-1 H-pyrazolo[3,4-pyrimidin-4[5H]-one (3).

 

1-phenyl-1 H-pyrazolo[3,4-d]pyrimidin-4[5H]-one (3a):

Rf 0.21 (Chloroform : Ethyl acetate (7 : 3)), IR (cm-1): IR (KBr) : 3165.3 cm–1 (–NH, 2° amide); 3018.2 cm–1 (=C–H, aromatic); 1733.6 cm–1 (–C=O); 1507.7 cm–1 (C=C, aromatic); 783.2 cm–1 (–CH oop), C11H8N4O (M.Wt. 212).

 

6-methyl-1-phenyl-1 H-pyrazolo[3,4-d]pyrimidin-4[5H]-one (3b):

Rf 0.24 (Chloroform : Ethyl acetate (7 : 3)), IR (cm-1): R (KBr) : 3127.3 cm–1 (–NH, 2° amide); 3014 cm–1 (=C–H, aromatic); 2930.6 cm–1 (–CH2–); 1684.9 cm–1 (–C=O); 1507.7 cm–1 (C=C, aromatic); 752.4 cm–1 (–CH oop), C12H10N4O (M.Wt. 226).

 

6-ethyl-1-phenyl-1 H-pyrazolo[3,4-d]pyrimidin-4[5H]-one (3c):

Rf 0.30 (Chloroform : Ethyl acetate (7 : 3)), IR (cm-1): IR (KBr) : 3127.3 cm–1 (–NH, 2° amide); 3019.6 cm–1 (=C–H, aromatic); 2935.6 cm–1 (–CH2–); 1683.2 cm–1 (–C=O); 1504.9 cm–1  (C=C, aromatic); 752.4                    cm–1 (–CH oop), C13H12N4O (M.Wt. 240).

 

6-propyl-1-phenyl-1 H-pyrazolo[3,4-d]pyrimidin-4[5H]-one (3d):

Rf 0.36 (Chloroform : Ethyl acetate (7 : 3)),  IR (cm-1): IR (KBr) : 3090.9 cm–1 (–NH, 2° amide); 3019.6 cm–1 (=C–H, aromatic); 2963.6 cm–1 (–CH2–); 1684.8 cm–1 (–C=O); 1504.3 cm–1 (C=C, aromatic); 758.1 cm–1 (–CH oop), C14H14N4O (M.Wt. 254).

 

1,6-diphenyl-1 H-pyrazolo[3,4-d]pyrimidin-4[5H]-one (3e):

Rf 0.42 (Chloroform : Ethyl acetate (7 : 3)), IR (cm-1): IR (KBr) : 3200 cm–1 (–NH, 2° amide); 3081 cm–1 (=C–H, aromatic); 2924.4 cm–1 (–CH2–); 1684.5 cm–1 (–C=O); 1507.7 cm–1 (C=C, aromatic); 758.1 cm–1 (–CH oop).,C17H12N4O (M.Wt. 288).

 

Using Method A and B, total 5 derivatives were prepared. The spectral data of compound (3a-e) obtained by Method A and B were found to be identical.

 

Procedure for determination of Antimicrobial activity:

Antimicrobial activity is determined based on the in-vitro activity in pure cultures. In-vitro susceptibility tests are done by agar diffusion method26, 27. In this technique petridishes of agar are prepared by pouring method. The agar is inoculated with microorganisms. In the agar dilution method different antibiotic concentrations are incorporated in to an agar medium for both aerobes and anaerobes. The plates are incubated at a temperature of 37ºC for 24 hours. The antimicrobial substance diffuses through the agar and produces a clear zone of inhibition. The diameter of this zone can be measured and an estimation of the degree of activity of the antimicrobial substance can be obtained.

 

Here, responses of microorganisms to the synthesized compounds were measured and compared with the response of the standard reference drug. The standard reference drug used in the present work was Streptomycin. Four microorganisms used were Klebsiella (Gram –ve), Escherichia coli (Gram –ve), Staphylococcus aureus (Gram +ve) and Bacillus subtillis (Gram +ve)28.   Each test compound was dissolved in Dimethyl sulfoxide (DMSO) to get a concentration of 500 μg/ml. This concentration was used for testing antibacterial activity. Mueller Hinton agar media 29, 30 was prepared of the composition as beef infusion 300 g, casamino acids 17.5 g, starch 1.5 g, agar 17 g, distilled water 1,000 ml. The beef extract was taken in a 1000 ml beaker and made up the volume to 1000 ml with water. To this mixture known quantities of beef infusion, agar, starch and casamino acids were added and dissolved by heating the mixture. The pH was adjusted to 7.3. Finally the media was sterilized by autoclaving at 121ºC for 15 minutes at 15-PSI (Pound per square inch) pressure. Afterwards the mixture was cooled to 45ºC and then inoculums were added to the above cooled media, mixed properly and poured into the sterile petridishes for solidifying. Bores were made on the medium using sterile borer. 0.1 ml of test solution and standard solution at a concentration of 50 μg/0.1 ml were taken. A standard (streptomycin) was maintained with same concentration in each plate and a control having only DMSO in one plate. Then the petridishes were incubated at 37ºC for 24 hours and zones of inhibition were observed and measured.

 

The suspensions (inoculums) of all the organisms were prepared as per standard procedure (Mcfarland Nephelometer Standard).  A 24 hour-old culture was used for the preparation of bacterial suspension. Suspensions of organisms were made in sterile isotonic solution of sodium chloride (0.9 % w/v).

 

RESULTS AND DISCUSSION:

In this work total 5 derivatives of pyrazolopyrimidines containing 6-substituted1-phenyl-1 H-pyrazolo[3,4-pyrimidin-4[5H]-one (3a-e) were prepared by both conventional and one pot microwave synthesis. In the first method (Method A), ester (2) was added to 5 -amino-1-phenyl pyrazole-4-carboxamide (APPC) (1) in a solvent such as sodium ethoxide. The reaction mixture was heated to reflux for 6-14 hours in an oil bath followed by filtration and neutralization with dilute hydrochloric acid to obtain 6-substituted-1-phenyl-1H-pyrazolo[3,4-d] pyrimidin-4[5H]-ones (3a-e) in 70-85 % yield. In second method (Method B), ester (2) was added to 5 -amino-1-phenyl pyrazole-4-carboxamide (APPC) (1) in a solvent such as sodium ethoxide in a test tube and irradiated for 3 minutes at 960 watt using domestic microwave oven followed by filtration and neutralization with dilute  hydrochloric acid to obtain 6-substituted-1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4[5H]-ones (3a-e) in 76-85 % yield.

 

All the titled compounds (3a-e) were characterized by their analytical and spectral data. The IR data of compounds (3a-e) showed characteristic C=O vibrations around 1700 cm-1 and –NH (2° amide) vibrations around 3175-3100 cm-1. This indicated the formation of the compound.

 

As shown in table no. 1, when the synthesis of compounds (3a-e) were attempted using conventional method (Method A), it took 6-14 hrs for the completion of reaction and the overall yield were found in the range of 70-85 %. When the same reaction was attempted using the one-pot microwave-assisted synthesis (Method B), reaction was successfully completed within 10-20 minutes and the overall yields were found in the range of 76-85%.


Table No. 1: Comparison between Microwave assisted method and Conventional method

Sr. No.

 

Compounds prepared

R

Conventional method ( Method A)

Microwave assisted method (Method B)

Time (hr.)

% Yield

Time (sec.)

% Yield

1

3a

H

14

82

180

85

2

3b

CH3

6

81

180

84

3

3c

C2H5

7

70

180

76

4

3d

C3H7

6

80

180

83

5

3e

C6H5

14

85

180

82

 

Table No. 2: Antibacterial activity of 6-substituted-1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4[5H]-ones (3a-e)                                      

 

Comp.

No.

R

Zone of inhibition (mm.)

 

Klebsiella

Gram (-ve)  

E. coli

Gram (-ve)

S. aureus

Gram (+ve)

B. subtillis

Gram (+ve)

 

I

II

Mean ±S.D.

I

II

Mean± S.D.

I

II

Mean±S.D.

I

II

Mean± S.D.

3a

H

12

11

11.5 ± 0.707

12

10

11 ± 1.414

09

07

08 ± 1.414

07

06

6.5 ± 0.707

3b

CH3

13

11

12 ± 1.414

10

11

10.5 ± 0.707

10

07

8.5 ± 2.12

08

08

08 ± 0.0

3c

C2H5

14

12

13 ± 1.414

09

08

8.5 ± 0.707

08

08

08 ± 0.0

07

08

7.5 ± 0.707

3d

C3H7

12

11

11.5 ± 0.707

12

10

11 ± 1.414

08

09

8.5 ± 0.707

06

07

6.5 ± 0.707

3e

C6H5

15

13

14 ± 1.414

08

10

09 ± 1.414

07

08

7.5 ± 0.707

08

06

07 ± 1.414

Streptomycin

--

25

23

24 ± 1.414

19

20

19.5 ± 0.707

18

16

17 ± 1.414

14

15

14.5 ± 0.707

 

 

 


Thus microwave-assisted synthesis of compounds (3a-e) were found to be time specific and compared to conventional method, it led to the formation of title compounds in short time and has resulted in comparable yields over the conventional methods.

 

The antibacterial activities of compounds  (3a-e) were tested against one strain each of a Gram +ve bacteria (Staphylococcus aureus), a Gram +ve spore (Bacillus subtillis), a Gram –ve bacteria (Escherichia coli) and a Gram –ve capsule (Klebsiella) using Streptomycin as a standard drug. From the data presented in table no. 2, it is clear that all the compounds were found to possess weak to moderate activity against all the microorganisms.

 

REFERENCES:

1.       Maekawa T., Sakai N., Tawada H., Murase K., Hazama M., Sugiyama Y. and Momose Y., Che. Pharm Bull, 51(5), 565-73, (2003)

2.       Lesieur and Aichaw H., EUR PAT., 390., 673., Chem Abstr, 114, 143 (1991)

3.       Sao Paulo., J Braz Chem Soc.,12 (3), (2001)

4.       Uckun F M., Current Pharmaceutical Design, 7 (16), 1627-1639 (2001)

5.       Kunes J., Balsanek V., Pour M and Buchta V., Czechoslovak Chemical Communications Abstracts, 66(12), 1809-1830 (2001)

6.       Ando K. and Asai N., EUR PAT., 385, 664, Chem Abstr, 114- 143, (1991)

7.       Descas P. and Jarry C., EUR PAT., 392, 929, Chem Abstr, 114- 143, (1990)

8.       Benedlt D. and Daniel V., J Med Chem, 37, 710 (1994)

9.       Pereira E. R., Sancelme M., Voldorie A. and Prudhomme M., Bio-org, Med Chem Lit, 7(190), 2503, (1997)

10.     Viti G., Namnicine R., Ricci R., Pestelline V., Abeli L and Funo M., Eur J Med Chem, 29, 401 (1994)

11.     http://en.wikipedia.org/wiki/antibiotic

12.     http://textbookofbacteriology.net/resantimicrobial.html

13.     Holla B.S., Mahalinga M., Karthikeyan M.S., Akberali P.M., Shetty N.S., Synthesis of some novel pyrazolo[3,4-d]pyrimidine derivatives as potential antimicrobial agents, Bioorg Med Chem, 14, 2040-47 (2006)

14.     Baraldi P.G., Giovanna P.M., Del Carmen N.M,. Patrizia B., Beatrice V., Roberto G,et al,   Antimicrobial and antitumor activity of n-heteroimmine-1,2,3-dithiazoles and their transformation in triazolo-, imidazo- and pyrazolopyrimidines,  Bioorg Med Chem, 10, 449-56 (2002)

15.     Lauria A., Bruno M., Diana P., Barraja P., Montalbane A., Cirrincione G., et al., Annelated pyrrolo-pyrimidines from amino-cyanopyrroles and BMMAs as leads for new DNA-interactive ring systems, Bioorg Med Chem, 13, 1545-53 (2005)

16.     Baraldi P.G., Tabrizi M.A., Bovero A., Avitabile B., Preti D., Fruttarolo F., et al,  Recent developments in the field of A2A and A3 adenosine receptor antagonists, Eur J Med Chem, 38, 367-82 (2003)

17.     Silvia S., Olga B., Paola F., Angelo R., Giulia M., Luisa M., et al, Synthesis and biological data of 4-amino-1-(2-chloro-2-phenylethyl)-1H-pyrazolo[3,4-b]pyridine-5-carboxylic acid ethyl esters, a new series of A1-adenosine receptor (A1AR) ligands, Bioorg Med Chem Lett, 11, 2529-31 (2001)

18.     Gatta F., Del Giudice M.R., Borioni A., Borea P.A., Dionisotti S., Ongini E., Synthesis of imidazolo[1,2-c]pyrazolo[4,3-e]pyrimidines, pyrazolo[4,3-e]1,2,4-triazolo[1,5-c] pyrimidines and 1,2,4-triazolo[5,1-i]purines: new potent adenosine A2 receptor antagonists, Eur J Med Chem, 28, 569-76 (1993)

19.     Russo F., Guccione S., Romeo G., Uccello BG., Pucci S., Caruso A., et al, Pyrazolothiazolopyrimidine derivatives as a novel class of anti-inflammatory or antinociceptive agents: synthesis, structural characterization and pharmacological evaluation,  Eur J Med Chem, 28, 363-76 (1993)

20.     Russo F, Guccione S, Romeo G, Monsu’Scolaro L, Pucci S, Caruso A, et al, Synthesis and pharmacological properties of pyrazolotriazolopyrimidine derivatives, Eur J Med Chem, 27, 73-80 (1992)

21.     Ram V. J., Haque N., Synthesis of functionalised pyrazoles and pyrazolo[3,4-d] pyrimidines as potential leishmanicides, Indian J Chem, 34B, 521-24 (1995)

22.     Argade N. D., Kalrale  B. K. and Gill C. H., Microwave assisted improved method for the synthesis of pyrazole containing 2,4,-Disubstituted Oxazole-5-one and their antimicrobial activity,  E-Journal of chemistry, 5 (1), 120-129, (2008)

23.     Sureja D. K., Synthesis of some novel heterofused pyrazolopyrimidines for biological activity, M.Pharma dissertation, (2006)

24.     Olofson R.A and Kendall R. V., J Org Chem, 35, 2246 (1970)

25.     Lidström P., Tierney J., Wathey B and Westman J., Tetrahedron, 57, 9225 (2001)

26.     Cruickshank R., Duguid J.P, Marmion B.P., Swain R.H., Medicinal microbiology, 12th ed. London: Churchil Livingstone, 196-202 (1975)

27.     Collins A.H., Microbiological methods, 2nd ed. London: Butterworth, (1976)

28.     Halliwell B., J Neurochem, 40, 324 (1992)

29.     http://www.acumediadcm.com/Acumedia%20Product%20Information%20Sheets/MuellerHinton.pdf

30.     Sharma B.K., Kaur H., In Environmental Chemistry. 1st ed. Meerut, India, Krishna Prakashan, (1994)

 

 

 

Received on 23.11.2011         Modified on 12.12.2011

Accepted on 30.12.2011         © AJRC All right reserved

Asian J. Research Chem. 5(1):  January 2012; Page 103-107